Anticoagulants in the treatment of deep vein thrombosis
- 1 August 2005
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 118 (8) , 13-20
- https://doi.org/10.1016/j.amjmed.2005.06.006
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Ximelagatran: the first oral direct thrombin inhibitorExpert Opinion on Investigational Drugs, 2004
- Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary EmbolismNew England Journal of Medicine, 2003
- Direct thrombin inhibitorsExpert Opinion on Pharmacotherapy, 2003
- Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous ThromboembolismNew England Journal of Medicine, 2003
- A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE IJournal of Thrombosis and Haemostasis, 2003
- Clinical and economic aspects of managing venous thromboembolism in the outpatient settingSeminars in Hematology, 2001
- A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous ThromboembolismNew England Journal of Medicine, 1999
- Comparison of the Efficacy and Safety of Low Molecular Weight Heparins and Unfractionated Heparin in the Initial Treatment of Deep Venous ThrombosisDrugs, 1996
- Pharmacokinetics of low-molecular-weight heparin and unfractionated heparin during elective aortobifemoral bypass graftingJournal of Vascular Surgery, 1991
- Pharmacokinetic Studies of Standard Unfractionated Heparin, and Low Molecular Weight Heparins in the RabbitSeminars in Thrombosis and Hemostasis, 1988